Previous reports have shown that KSHV de novo infection of HMVEC-d requires ROS for Nrf2 activation during the early stages of infection and establishment of latency and observed activated Nrf2 levels in KSHV positive KS and Primary Effusion Lymphoma (PEL) lesion cells (46). The gene discussed is NFE2L2; the disease is Kaposi's sarcoma.